» Articles » PMID: 16477537

Adipose Tissue and Circulating Endothelial Cell Specific Molecule-1 in Human Obesity

Overview
Journal Horm Metab Res
Specialty Endocrinology
Date 2006 Feb 16
PMID 16477537
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Adipocytes produce the endothelial-cell specific molecule-1 (ESM-1), which inhibits leukocyte adhesion and migration through the endothelium. This study investigates ESM-1 expression and regulation in human adipose tissue. Subcutaneous abdominal adipose tissue was obtained from seventy postmenopausal women. Fourteen women subsequently underwent non-pharmacological weight reduction. In vitro experiments were performed on adipocytes isolated from human mammary adipose tissue. We determined gene expression by TaqMan RT-PCR and measured ESM-1 levels in serum and cell culture medium by ELISA. Mature adipocytes produced ESM-1. ESM-1 gene expression was higher in adipocytes than in preadipocytes. Cortisol inhibited ESM-1 gene expression in preadipocytes. Insulin and cortisol inhibited adipocyte ESM-1 production in adipocytes. This inhibitory effect of insulin was attenuated by insulin resistance, as ESM-1 gene expression in subcutaneous adipose tissue was increased in obese, hyperinsulinemic women. In contrast, ESM-1 serum levels were reduced in obese women and inversely correlated to C-reactive protein levels. Five percent weight loss did not markedly change gene expression. Circulating ESM-1 levels increased significantly, albeit modestly. ESM-1 is actively produced by adipocytes. However, since ESM-1 adipocyte gene expression and circulating plasma levels are not correlated, other sources of ESM-1 may be more important. Circulating ESM-1 levels are reduced in the overweight and obese, consistent with the notion that ESM-1 may play some role in obesity-associated vascular disease.

Citing Articles

Endocan, a novel glycoprotein with multiple biological activities, may play important roles in neurological diseases.

Liu S, Bai T, Feng J Front Aging Neurosci. 2024; 16:1438367.

PMID: 39328246 PMC: 11426085. DOI: 10.3389/fnagi.2024.1438367.


Dietary sulfur amino acid restriction in humans with overweight and obesity: a translational randomized controlled trial.

Olsen T, Stolt E, Ovrebo B, Elshorbagy A, Tore E, Lee-Odegard S J Transl Med. 2024; 22(1):40.

PMID: 38195568 PMC: 10775517. DOI: 10.1186/s12967-023-04833-w.


The Evaluation of Serum Endocan, Interleukin-6, and CRP Levels Following Sleeve Gastrectomy.

Sariyildiz G, Cicek Demir C, Demir M, Arslan A, Banli O, Dursun A Int J Gen Med. 2023; 16:4737-4744.

PMID: 37877002 PMC: 10591641. DOI: 10.2147/IJGM.S436213.


Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients.

Morace C, Curatola S, Mandraffino G, Scuruchi M, Serrano A, Tropeano A Ital J Pediatr. 2023; 49(1):108.

PMID: 37653524 PMC: 10468868. DOI: 10.1186/s13052-023-01510-y.


Evaluation of subclinical atherosclerosis in obese patients with three noninvasive methods: Arterial stiffness, carotid intima-media thickness, and biomarkers of endothelial dysfunction.

Can M, Kocabas M, Yarar Z, Burgucu H, Karakose M, Yerlikaya F Arch Endocrinol Metab. 2023; 67(4):e000622.

PMID: 37252704 PMC: 10665069. DOI: 10.20945/2359-3997000000622.